Literature DB >> 876382

Abrogation of reaginic antibodies with modified allergens.

W Y Lee, A H Sehon.   

Abstract

Mesh:

Substances:

Year:  1977        PMID: 876382     DOI: 10.1038/267618a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  19 in total

Review 1.  Can persistent IgE responses be suppressed?

Authors:  D M Kemeny; D Diaz-Sanchez
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

2.  Tolerogenic activity of polyethylene glycol-conjugated lysozyme distinct from that of the native counterpart.

Authors:  H O Ito; T So; M Hirata; T Koga; T Ueda; T Imoto
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

3.  Synthesis of tolerogenic monomethoxypolyethylene glycol and polyvinyl alcohol conjugates of peptides.

Authors:  M Z Atassi; T Manshouri
Journal:  J Protein Chem       Date:  1991-12

Review 4.  T-cell subsets in the pathogenesis of human asthma.

Authors:  Flurina Meiler; Maya Zimmermann; Kurt Blaser; Cezmi A Akdis; Mübeccel Akdis
Journal:  Curr Allergy Asthma Rep       Date:  2006-03       Impact factor: 4.806

5.  Immunotherapy in respiratory allergy.

Authors:  R J Davies
Journal:  Thorax       Date:  1983-06       Impact factor: 9.139

Review 6.  Recent studies on the regulation of IgE antibody synthesis in experimental animals and man.

Authors:  D H Katz
Journal:  Immunology       Date:  1980-09       Impact factor: 7.397

7.  Anti-immunoglobulin E antibody treatment blocks histamine release and tissue contraction in sensitized mice.

Authors:  M Haak-Frendscho; R Saban; R L Shields; P M Jardieu
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

8.  Adjuvant and suppressive effects of Grass Conjuvac and other alginate conjugates on IgG and IgE antibody responses in mice.

Authors:  W A Taylor; D Sheldon; J W Spicer
Journal:  Immunology       Date:  1981-09       Impact factor: 7.397

9.  Epitope-specific suppression of antibody response in experimental autoimmune myasthenia gravis by a monomethoxypolyethylene glycol conjugate of a myasthenogenic synthetic peptide.

Authors:  M Z Atassi; K H Ruan; K Jinnai; M Oshima; T Ashizawa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

10.  Administration of an anti-IgE antibody inhibits CD23 expression and IgE production in vivo.

Authors:  M Haak-Frendscho; K Robbins; R Lyon; R Shields; J Hooley; M Schoenhoff; P Jardieu
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.